{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:42:59Z","timestamp":1791276179021,"version":"4.1.0"},"reference-count":92,"publisher":"Wiley","issue":"23","license":[{"start":{"date-parts":[[2003,8,20]],"date-time":"2003-08-20T00:00:00Z","timestamp":1061337600000},"content-version":"vor","delay-in-days":992,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Biochemistry"],"published-print":{"date-parts":[[2000,12]]},"abstract":"<jats:p>The neuromuscular junction is the target of a variety of autoimmune, neurotoxic and genetic disorders, most of which result in muscle weakness. Most of the diseases, and many neurotoxins, target the ion channels that are essential for neuromuscular transmission. Myasthenia gravis is an acquired autoimmune disease caused in the majority of patients by antibodies to the acetylcholine receptor, a ligand\u2010gated ion channel. The antibodies lead to loss of acetylcholine receptor, reduced efficiency of neuromuscular transmission and muscle weakness and fatigue. Placental transfer of these antibodies in women with myasthenia can cause fetal or neonatal weakness and occasionally severe deformities. Lambert Eaton myasthenic syndrome and acquired neuromyotonia are caused by antibodies to voltage\u2010gated calcium or potassium channels, respectively. In the rare acquired neuromyotonia, reduced repolarization of the nerve terminal leads to spontaneous and repetitive muscle activity. In each of these disorders, the antibodies are detected by immunoprecipitation of the relevant ion channel labelled with radioactive neurotoxins. Genetic disorders of neuromuscular transmission are due mainly to mutations in the genes for the acetylcholine receptor. These conditions show recessive or dominant inheritance and result in either loss of receptors or altered kinetics of acetylcholine receptor channel properties. Study of these conditions has greatly increased our understanding of synaptic function and of disease aetiology.<\/jats:p>","DOI":"10.1046\/j.1432-1033.2000.01785.x","type":"journal-article","created":{"date-parts":[[2003,8,20]],"date-time":"2003-08-20T07:48:59Z","timestamp":1061365739000},"page":"6717-6728","source":"Crossref","is-referenced-by-count":71,"title":["Molecular targets for autoimmune and genetic disorders of neuromuscular transmission"],"prefix":"10.1111","volume":"267","author":[{"given":"Angela","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,8,20]]},"reference":[{"key":"e_1_2_8_2_2","volume-title":"The Physiology of Excitable Cells.","author":"Aidley D.J.","year":"1999"},{"key":"e_1_2_8_3_2","volume-title":"Neuromuscular Transmission: Basic and Applied Aspects.","author":"Vincent A.","year":"1992"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(05)80031-5"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1999.00765.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.22.1.389"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.140.3.675"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(90)90079-U"},{"key":"e_1_2_8_9_2","first-page":"267","article-title":"Spatial relationships of utrophin, dystrophin, b\u2010dystroglycan and b\u2010spectrin to acetylcholine receptor clusters during postnatal maturation of the rat neuromuscular junction","volume":"25","author":"Bewick G.S.","year":"1996","journal-title":"J. Neurocytol."},{"key":"e_1_2_8_10_2","volume-title":"Natural and Synthetic Neurotoxins. Neuroscience Perspectives.","author":"Harvey A.L.","year":"1993"},{"key":"e_1_2_8_11_2","first-page":"1","article-title":"Recent advances in chemistry and pharmacology of snake toxins","volume":"3","author":"Lee C.Y.","year":"1979","journal-title":"Adv. Cytopharmacol."},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.63.070194.004135"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11424.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90004-7"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1996.0539u.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1999.2721"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(97)00118-6"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.2.755"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1998.tb01190.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00357a051"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1992.tb17124.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/08916939409007984"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/107385849700300515"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb141345.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406233302507"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1964.sp007495"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.180.4088.871"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7384786"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1101\/SQB.1983.048.01.008"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4109.293"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/003693306000501001"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.26.11.1054"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.3.266"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197701202960301"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410160502"},{"key":"e_1_2_8_36_2","volume-title":"Autoimmune Disease Models","author":"Vincent A.","year":"1994"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1998.tb01217.x"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51286.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00086-7"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197805182982004"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.663610"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.46.5.383"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117302"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51301.x"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430315"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117369"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92652-6"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.1996.0253"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119048"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(20000501)92:1<1::AID-AJMG1>3.0.CO;2-H"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5943"},{"key":"e_1_2_8_52_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity","volume":"1","author":"Mossman S.","year":"1986","journal-title":"Lancet"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300407"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb22936.x"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.15.5728"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200011)48:5<696::AID-ANA2>3.0.CO;2-S"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/111.3.577"},{"key":"e_1_2_8_59_2","first-page":"689","article-title":"Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma","volume":"43","author":"Elmqvist D.","year":"1968","journal-title":"Mayo Clin. Proc."},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1971.tb30750.x"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880050905"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90474-8"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1983.sp014943"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410220204"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(92)90053-B"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.5.1391"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-1775-1_2"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1995.sp020865"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021800"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/317737a0"},{"key":"e_1_2_8_71_2","first-page":"4719","article-title":"Antagonism of voltage\u2010gated calcium channels in small cell carcinomas of patients with and without Lambert\u2013Eaton myasthenic syndrome by autoantibodies, W\u2010conotoxin and adenosine","volume":"48","author":"De Aizpurua H.J.","year":"1988","journal-title":"Cancer Res."},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.2.334"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10992.x"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(96)05303-8"},{"key":"e_1_2_8_75_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.1.85"},{"key":"e_1_2_8_76_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506013322203"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.14.8328"},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420204"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1999.tb00226.x"},{"key":"e_1_2_8_80_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(00)02585-X","article-title":"Screening for autoantibodies in cerebellar ataxia","volume":"356","author":"Trivedi R.","journal-title":"Lancet"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/116.2.453"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90073-X"},{"key":"e_1_2_8_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410215"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880040407"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.2.163"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199910)46:4<639::AID-ANA13>3.0.CO;2-1"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199904)45:4<439::AID-ANA4>3.0.CO;2-W"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410110603"},{"key":"e_1_2_8_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90080-2"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.5.767"},{"key":"e_1_2_8_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2<162::AID-ANA5>3.0.CO;2-Q"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81373-2"},{"key":"e_1_2_8_93_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.4.1317"}],"container-title":["European Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1432-1033.2000.01785.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1432-1033.2000.01785.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T17:50:24Z","timestamp":1698774624000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1432-1033.2000.01785.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":92,"aliases":["10.1046\/j.1432-1327.2000.01785.x"],"journal-issue":{"issue":"23","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["10.1046\/j.1432-1033.2000.01785.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1432-1033.2000.01785.x","archive":["Portico"],"relation":{},"ISSN":["0014-2956","1432-1033"],"issn-type":[{"value":"0014-2956","type":"print"},{"value":"1432-1033","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}